Design (Testphase)
Risk & Weakness
Pradeep Bonde: $ Breakout Bearish
134
Findings
August 3, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · showing the 100 strongest hits
Bonde's dollar breakdown (original Stockbee formula 'o−c ≥ 0.90'): the stock closes at least $0.90 below its opening price — sustained selling pressure across the whole trading day, measured in dollars. Minimum daily volume 100,000 shares, average volume (50 days) ≥ 100,000 as a liquidity filter. Opening price calculated from the prior close and the gap.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Fundamental Rating ≥ 55 out of 100) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(18)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Breakout
- The price clears a level where it previously failed multiple times (top of a base, an old high) - ideally on clearly elevated volume. For many momentum strategies, the breakout is the actual buy signal.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
- Gap
- The stock opens well above or below the prior close - a gap appears on the chart. Gaps are caused by overnight news (earnings, contracts, studies) and show that the valuation has shifted abruptly.
- Liquidity
- How easily a stock can be bought and sold without moving the price - measured by (dollar) volume. Illiquid stocks have wide spreads and jerky prices; that is why almost every scanner applies a minimum liquidity filter.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SYRE Spyre Therapeutics Inc. | 08/04 | +290 % | 79 7/22 | Stage 2 | D 32 | 2 of 9 | 8.8 $ | Biotechnology | – | — | — | Healthcare | 98.30 $ | +196.2 % | +172.8 % | +479.4 % | −13.1 % | +7.6 % | 99 | 1 | 7.6 % | 6.7 % | 3.02 | — | 0.0 | 97.5 | 16.6 | — | — | -8.0 | 0.0 % | — | 0.0 % | -31.1 % | -22.7 % | — | 87.8 % | -100.0 % | — | 0.0 % | 0.0 % | 9.5 | 93.2 % | 15.4 % | 4.8 (11) |
| ANRO Alto Neuroscience, Inc. | 08/12 | — | 89 8/22 | Stage 2 | D 26 | 2 of 9 | 1.0 $ | Biotechnology | – | — | — | Healthcare | 27.10 $ | +37.3 % | +41.2 % | +781.8 % | −11.0 % | +31.5 % | 99 | 42 | 8.0 % | 7.7 % | 1.07 | — | 0.0 | — | 3.9 | — | — | 0.0 | — | — | 0.0 % | -38.9 % | -21.7 % | 0.02 | — | -100.0 % | — | 0.0 % | 0.0 % | 12.7 | 82.1 % | 9.4 % | 4.6 (8) |
| PRAX Praxis Precision Medicines Inc | 08/03 | +177 % | 96 10/22 | Stage 2 | C 54 | 4 of 9 | 8.5 $ | Biotechnology | – | — | — | Healthcare | 307.80 $ | +3.6 % | +27.6 % | +467.7 % | −10.6 % | +98.2 % | 98 | 42 | 6.8 % | 7.0 % | 2.76 | — | 0.0 | — | 5.7 | — | — | -6.9 | 0.0 % | -3,809.4 % | 0.0 % | -35.3 % | -23.0 % | 0.00 | 96.6 % | -100.0 % | — | 0.0 % | 0.0 % | 31.8 | 116.8 % | 13.5 % | 4.4 (12) |
| UCTT Ultra Clean Holdings Inc | 07/27 | +70 % | 92 10/25 | Stage 2 | C 45 | 2 of 9 | 4.1 $ | Semiconductor Equipment & Materials | Uses AI | — | Technology | 83.30 $ | +340.7 % | +399.2 % | +269.9 % | −3.5 % | +39.7 % | 98 | 17 | 8.9 % | 8.7 % | 1.83 | — | 34.6 | 2.0 | 5.9 | — | 0.99 | 349.0 | 2.1 % | 15.6 % | -9.4 % | -22.5 % | 1.4 % | 1.52 | 33.9 % | -2.1 % | — | 0.0 % | 0.0 % | 6.3 | 102.9 % | 10.7 % | 4.8 (4) | |
| ORKA Oruka Therapeutics, Inc. | 08/10 | +78 % | 79 7/22 | Stage 2 | D 33 | 1 of 9 | 6.0 $ | Biotechnology | – | — | — | Healthcare | 96.50 $ | +175.2 % | +188.0 % | +610.2 % | −4.8 % | +53.5 % | 98 | 42 | 7.5 % | 6.8 % | — | — | 0.0 | — | 12.0 | — | — | 0.0 | 0.0 % | — | 0.0 % | -27.3 % | -18.9 % | 0.00 | 96.5 % | +1,105.3 % | — | 0.0 % | 0.0 % | 34.0 | 89.1 % | 22.3 % | 4.9 (8) |
| DFTX Definium Therapeutics, Inc. | 07/30 | +332 % | — | Stage 2 | D 26 | 1 of 9 | 0.0 $ | Biotechnology | Neutral | — | Healthcare | 43.50 $ | +170.2 % | +246.6 % | +378.8 % | −4.7 % | +24.7 % | 98 | 50 | 14.0 % | 8.8 % | 2.21 | — | 0.0 | — | 21.7 | — | — | 0.0 | 0.0 % | — | 0.0 % | -94.7 % | -35.7 % | — | 69.5 % | — | — | 0.0 % | 0.0 % | 1.4 | 65.6 % | 9.8 % | — | |
| AIP Arteris Inc | 08/04 | +177 % | 61 6/25 | Stage 2 | C 48 | 3 of 9 | 1.4 $ | Semiconductors | Sells AI | — | — | Technology | 29.90 $ | +165.9 % | +197.1 % | +203.0 % | −3.8 % | +27.8 % | 98 | 42 | 7.1 % | 7.5 % | 1.92 | — | 0.0 | 18.4 | 501.5 | — | — | -7.7 | -38.0 % | 88.8 % | -44.9 % | -1,369.6 % | -17.9 % | 2.11 | 1.8 % | +22.3 % | — | 0.0 % | 0.0 % | -3.7 | 61.1 % | 7.3 % | 4.5 (4) |
| RVMD Revolution Medicines Inc | 08/05 | +188 % | 38 4/22 | Stage 2 | D 41 | 1 of 9 | 39.0 $ | Biotechnology | – | — | — | Healthcare | 187.50 $ | +112.8 % | +137.2 % | +403.2 % | −3.4 % | +10.4 % | 97 | 42 | 4.8 % | 4.4 % | 1.38 | — | 0.0 | — | 27.2 | — | — | -9.7 | 0.0 % | -151,691.8 % | 0.0 % | -76.7 % | -37.5 % | 0.29 | 66.6 % | -100.0 % | — | 0.0 % | 0.0 % | 1.4 | 95.7 % | 7.0 % | 4.7 (12) |
| CIFR Cipher Mining Inc | 08/06 | +284 % | 60 6/25 | Stage 2 | D 38 | 4 of 9 | 9.3 $ | Information Technology Services | – | — | — | Technology | 22.30 $ | +87.3 % | +53.1 % | +308.8 % | −14.8 % | +47.1 % | 97 | 65 | 10.3 % | 10.5 % | 3.20 | — | 85.5 | 50.3 | 13.0 | — | — | 54.2 | -249.4 % | 12.4 % | 0.0 % | -121.7 % | -0.2 % | — | 11.2 % | +48.0 % | — | 0.0 % | 0.0 % | 5.4 | 81.2 % | 16.7 % | 4.7 (16) |
| RLAY Relay Therapeutics Inc | 08/06 | +16 % | 88 8/22 | Stage 2 | D 27 | 3 of 9 | 4.1 $ | Biotechnology | – | — | — | Healthcare | 18.80 $ | +106.1 % | +128.2 % | +434.9 % | −5.9 % | +38.7 % | 97 | 42 | 6.4 % | 8.1 % | 1.68 | — | 0.0 | 379.8 | — | — | — | -0.8 | -2,619.7 % | -2,300.3 % | 0.0 % | -40.0 % | -24.7 % | — | 91.8 % | +53.4 % | — | 0.0 % | 0.0 % | 8.5 | 87.0 % | 22.8 % | 4.3 (13) |
| MBX MBX Biosciences, Inc. | 08/06 | — | 69 6/22 | Stage 2 | D 34 | 3 of 9 | 3.0 $ | Biotechnology | Neutral | — | Healthcare | 65.90 $ | +47.1 % | +67.7 % | +397.6 % | −4.1 % | +22.0 % | 97 | 42 | 8.5 % | 7.7 % | — | — | 0.0 | — | 7.2 | — | — | 0.0 | 0.0 % | — | 0.0 % | -25.7 % | -17.7 % | 0.00 | 96.7 % | — | — | 0.0 % | 0.0 % | 37.2 | 111.5 % | 17.0 % | 4.6 (5) | |
| INBX Inhibrx Biosciences, Inc. | 08/12 | — | 55 5/22 | Stage 2 | D 32 | 2 of 9 | 1.3 $ | Biotechnology | Neutral | — | — | Healthcare | 82.10 $ | +17.6 % | +18.8 % | +274.3 % | −38.6 % | +238.0 % | 97 | 42 | 6.9 % | 7.5 % | 3.43 | — | 0.0 | 965.4 | 182.9 | — | — | 0.0 | — | -7,697.5 % | 0.0 % | -354.7 % | -36.1 % | -0.28 | — | +550.0 % | — | 0.0 % | 0.0 % | -1.0 | 83.1 % | 31.3 % | — |
| FCEL FuelCell Energy Inc | — | -22 % | 85 10/29 | Stage 2 | C 46 | 4 of 9 | 1.6 $ | Electrical Equipment & Parts | Neutral | — | Industrials | 21.60 $ | +198.5 % | +239.8 % | +335.7 % | −29.0 % | +5.7 % | 97 | 42 | 20.4 % | 18.0 % | 2.31 | — | 17.1 | 9.7 | 2.0 | — | 0.36 | 3,082.7 | — | -18.2 % | -132.4 % | -30.7 % | -7.7 % | 0.22 | — | +41.1 % | — | 0.0 % | 0.0 % | 1.4 | 38.6 % | 18.9 % | 2.6 (8) | |
| ARWR Arrowhead Pharmaceuticals Inc | 08/06 | +42 % | 53 5/22 | Stage 2 | D 40 | 3 of 9 | 11.9 $ | Biotechnology | – | — | — | Healthcare | 84.70 $ | +20.3 % | +14.8 % | +435.8 % | −6.2 % | +27.6 % | 96 | 58 | 4.9 % | 5.1 % | 1.27 | — | 111.1 | 19.2 | 19.4 | — | — | 27.9 | -191.6 % | 100.0 % | -48.4 % | -42.4 % | -7.2 % | 2.24 | 27.1 % | +23,258.2 % | — | 0.0 % | 0.0 % | 5.1 | 88.6 % | 9.5 % | 4.4 (13) |
| TWST Twist Bioscience Corp | 08/03 | +131 % | 54 5/22 | Stage 2 | D 43 | 4 of 9 | 5.7 $ | Diagnostics & Research | Threatened | — | Healthcare | 91.60 $ | +168.0 % | +192.9 % | +172.7 % | −1.8 % | +1.0 % | 96 | 42 | 7.7 % | 7.8 % | 2.12 | — | 0.0 | 13.9 | 12.9 | — | — | -35.3 | -34.9 % | 52.1 % | -19.9 % | -18.2 % | -12.9 % | 0.21 | 67.3 % | +20.3 % | — | 0.0 % | 0.0 % | -0.1 | 123.8 % | 29.1 % | 4.2 (12) | |
| CELC Celcuity LLC | 08/13 | +65 % | 80 7/22 | Stage 1 | C 47 | 2 of 9 | 4.3 $ | Biotechnology | Neutral | — | — | Healthcare | 86.40 $ | -9.6 % | -0.1 % | +120.6 % | −36.5 % | +89.3 % | 96 | 42 | 5.5 % | 7.2 % | 0.16 | — | 0.0 | 21,410.0 | — | — | — | -7.8 | 0.0 % | — | 0.0 % | -275.2 % | -37.1 % | — | 13.1 % | — | — | 0.0 % | 0.0 % | 2.6 | 101.2 % | 34.4 % | 4.7 (7) |
| DNTH Dianthus Therapeutics Inc. | 08/06 | +247 % | — | Stage 2 | D 37 | 4 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 106.90 $ | +112.4 % | +121.7 % | +417.3 % | −5.1 % | +39.4 % | 96 | 50 | 5.9 % | 6.6 % | 0.09 | — | 0.0 | — | — | — | — | -7.3 | -10,050.3 % | 100.0 % | 0.0 % | -22.7 % | -15.0 % | — | 96.4 % | -67.4 % | — | 0.0 % | 0.0 % | 35.6 | 120.4 % | 14.7 % | 1.0 (12) |
| AMBQ Ambiq Micro, Inc. | — | — | — | Stage 2 | C 51 | 4 of 9 | 0.0 $ | Semiconductors | – | — | — | Technology | 63.60 $ | +179.9 % | +175.9 % | +45.0 % | −8.9 % | -15.9 % | 96 | 50 | 8.1 % | 8.7 % | — | — | 0.0 | — | 7.9 | — | — | 0.0 | -46.6 % | 42.3 % | -46.9 % | -24.5 % | -14.8 % | 0.01 | 90.6 % | -4.7 % | — | 0.0 % | 0.0 % | 13.4 | 64.2 % | 7.3 % | — |
| RIOT Riot Platforms, Inc. | 07/30 | +49 % | 78 7/22 | Stage 2 | D 31 | 2 of 9 | 7.7 $ | Capital Markets | Sells AI | — | Financial Services | 20.20 $ | +126.4 % | +99.4 % | +50.4 % | −8.4 % | +46.9 % | 95 | 74 | 7.9 % | 7.5 % | 3.81 | — | 20.9 | 11.8 | 3.2 | — | — | 11.4 | -280.5 % | 32.4 % | -132.8 % | -32.5 % | -12.1 % | 0.39 | 69.7 % | +71.9 % | — | 0.0 % | 0.0 % | 3.1 | 81.6 % | 15.3 % | 4.5 (16) | |
| ONTO Onto Innovation Inc | 08/06 | +67 % | 78 8/25 | Stage 2 | C 47 | 2 of 9 | 14.2 $ | Semiconductor Equipment & Materials | – | — | — | Technology | 258.60 $ | +100.1 % | +117.1 % | +172.9 % | −2.5 % | +42.9 % | 95 | 15 | 8.1 % | 7.3 % | 1.55 | 113.7 | 36.1 | 13.7 | 5.7 | 59.3 | 1.20 | 61.5 | 16.8 % | 54.2 % | 10.3 % | 5.3 % | 5.4 % | — | 89.0 % | +1.8 % | — | 0.0 % | 0.0 % | 16.2 | 100.4 % | 6.8 % | 4.1 (9) |
| COGT Cogent Biosciences Inc | 08/04 | +12 % | 26 3/22 | Stage 1 | D 41 | 4 of 9 | 6.6 $ | Biotechnology | – | — | — | Healthcare | 38.90 $ | +2.2 % | -2.5 % | +240.9 % | −13.1 % | +39.5 % | 95 | 42 | 4.5 % | 4.5 % | 0.34 | — | 0.0 | — | 12.1 | — | — | -3.9 | 0.0 % | — | 0.0 % | -85.7 % | -38.1 % | 0.39 | 67.3 % | -100.0 % | — | 0.0 % | 0.0 % | 4.1 | 112.3 % | 9.8 % | 4.2 (12) |
| CEVA CEVA Inc | 08/10 | +32 % | 73 7/25 | Stage 2 | C 52 | 1 of 9 | 0.9 $ | Semiconductors | – | — | — | Technology | 32.70 $ | +111.3 % | +97.2 % | +52.8 % | −14.9 % | +52.9 % | 95 | 85 | 8.4 % | 8.2 % | 1.97 | — | 64.1 | 8.1 | 2.7 | — | 3.20 | 126.8 | — | 87.2 % | -10.5 % | -3.9 % | -2.2 % | 0.05 | — | +2.5 % | — | 0.0 % | 0.0 % | 14.5 | 92.3 % | 7.4 % | 4.8 (8) |
| PVLA Palvella Therapeutics, Inc | 08/13 | +73 % | 27 3/22 | Stage 2 | D 28 | 3 of 9 | 2.0 $ | Biotechnology | – | — | — | Healthcare | 139.00 $ | +13.4 % | +46.3 % | +280.1 % | −9.9 % | +65.2 % | 95 | 42 | 7.0 % | 6.4 % | — | — | 0.0 | — | 8.6 | — | — | 0.0 | — | — | 0.0 % | -34.3 % | -16.6 % | 0.00 | — | -100.0 % | — | 0.0 % | 0.0 % | 14.3 | 96.4 % | 17.2 % | 4.8 (9) |
| NVCT Nuvectis Pharma Inc | 08/04 | +1 % | 82 7/22 | Stage 2 | E 24 | 1 of 9 | 0.7 $ | Biotechnology | – | — | — | Healthcare | 21.50 $ | +132.5 % | +270.0 % | +209.2 % | −0.2 % | +47.9 % | 95 | 42 | 16.4 % | 9.8 % | -0.25 | — | 0.0 | — | — | — | — | -7.4 | — | — | 0.0 % | -154.4 % | -63.6 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -7.1 | 18.2 % | 7.3 % | 4.3 (6) |
| STRZ Starz Entertainment LLC | — | — | — | Stage 2 | E 19 | 4 of 9 | 0.0 $ | Entertainment | – | — | — | Communication Services | 26.00 $ | +143.2 % | +152.5 % | +78.8 % | −9.7 % | +15.0 % | 94 | 50 | 6.8 % | 7.1 % | — | — | 3.6 | — | — | — | — | 1.7 | — | 50.7 % | -13.2 % | -34.7 % | -0.8 % | — | — | -8.2 % | — | 0.0 % | 0.0 % | 1.3 | 92.3 % | 3.7 % | — |
| FEIM Frequency Electronics Inc | 07/09 | +353 % | 62 6/25 | Stage 2 | D 44 | 3 of 9 | 0.6 $ | Communication Equipment | Neutral | — | — | Technology | 58.00 $ | +28.1 % | +9.2 % | +117.9 % | −21.8 % | +39.7 % | 94 | 4 | 8.0 % | 8.3 % | 0.64 | 79.4 | 14.2 | 9.1 | 9.5 | — | 1.25 | 84.3 | — | 35.1 % | -1.4 % | 12.9 % | 0.8 % | 0.14 | — | +26.3 % | — | 0.0 % | 0.0 % | 7.9 | 74.2 % | 12.4 % | — |
| CORZ Core Scientific, Inc. | 08/14 | — | 46 5/25 | Stage 2 | D 44 | 4 of 9 | 6.6 $ | Software - Infrastructure | – | — | — | Technology | 20.70 $ | +100.3 % | +66.6 % | +53.0 % | −10.5 % | +79.3 % | 93 | 80 | 6.3 % | 6.5 % | 5.50 | — | 166.7 | 14.9 | 0.0 | — | — | 454.9 | -18.8 % | 32.1 % | 0.0 % | 0.0 % | -2.4 % | -1.57 | -42.5 % | -37.5 % | — | 0.0 % | 0.0 % | -5.1 | 124.5 % | 22.6 % | 4.7 (16) |
| EWTX Edgewise Therapeutics Inc | 08/06 | +137 % | 13 2/22 | Stage 2 | D 26 | 3 of 9 | 3.9 $ | Biotechnology | – | — | — | Healthcare | 38.40 $ | +56.5 % | +49.9 % | +169.5 % | −5.1 % | +30.0 % | 93 | 42 | 7.6 % | 6.7 % | 0.28 | — | 0.0 | — | 8.5 | — | — | -2.6 | 0.0 % | — | 0.0 % | -38.1 % | -25.6 % | 0.01 | 95.1 % | — | — | 0.0 % | 0.0 % | 23.8 | 113.9 % | 13.3 % | 4.3 (10) |
| CGEM Cullinan Oncology LLC | 08/06 | +14 % | 55 5/22 | Stage 2 | C 47 | 1 of 9 | 1.0 $ | Biotechnology | – | — | — | Healthcare | 16.50 $ | +71.5 % | +79.5 % | +112.4 % | −1.5 % | +91.7 % | 93 | 42 | 8.3 % | 8.2 % | -0.01 | — | 6.7 | — | — | — | — | -1.5 | — | — | 0.0 % | -48.2 % | -30.6 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | 10.2 | 107.8 % | 23.8 % | 4.9 (9) |
| MRNA Moderna Inc | 08/07 | -16 % | 25 3/22 | Stage 2 | C 53 | 3 of 9 | 21.7 $ | Biotechnology | – | — | — | Healthcare | 54.80 $ | +106.8 % | +112.8 % | +85.5 % | −11.8 % | -9.7 % | 92 | 5 | 9.7 % | 7.0 % | 0.94 | — | 23.0 | 9.8 | 2.9 | — | — | 4.6 | -131.1 % | -66.0 % | -141.4 % | -36.6 % | -13.3 % | 0.18 | 64.5 % | -39.2 % | — | 0.0 % | 0.0 % | 6.9 | 79.0 % | 16.2 % | 3.2 (27) |
| RAPP Rapport Therapeutics, Inc. | 08/06 | — | 55 5/22 | Stage 2 | D 33 | 4 of 9 | 1.9 $ | Biotechnology | – | — | — | Healthcare | 41.00 $ | +28.1 % | +30.6 % | +185.4 % | −8.0 % | +42.9 % | 92 | 42 | 6.0 % | 6.1 % | 0.95 | — | 0.0 | 96.4 | 4.2 | — | — | 0.0 | — | 34.3 % | 0.0 % | -28.3 % | -19.1 % | 0.02 | — | — | — | 0.0 % | 0.0 % | 25.1 | 109.6 % | 8.9 % | 4.8 (5) |
| AVTX Avalo Therapeutics Inc | 08/06 | -33 % | 41 4/22 | Stage 3 | E 17 | 2 of 9 | 1.0 $ | Biotechnology | – | — | — | Healthcare | 18.30 $ | -1.8 % | +2.0 % | +131.3 % | −25.8 % | +144.2 % | 91 | 42 | 7.7 % | 7.4 % | 0.79 | — | 0.0 | 9,860.0 | — | — | — | -0.2 | — | -66,988.1 % | 0.0 % | -88.8 % | -41.5 % | — | — | -86.6 % | — | 0.0 % | 0.0 % | -10.4 | 76.6 % | 24.0 % | 4.6 (8) |
| SATS EchoStar Corporation | 07/30 | +170 % | 84 8/24 | Stage 1 | D 28 | 4 of 9 | 28.2 $ | Telecom Services | Neutral | — | — | Communication Services | 92.00 $ | -4.4 % | -5.7 % | +313.2 % | −34.0 % | +49.6 % | 90 | 5 | 6.8 % | 7.3 % | 0.96 | — | 1.7 | 1.9 | 5.0 | — | 1.33 | 20.1 | 8.9 % | 27.1 % | -97.6 % | -112.3 % | 0.4 % | 5.20 | 13.6 % | -5.2 % | — | 0.0 % | 0.0 % | -0.9 | 112.2 % | 36.5 % | 3.7 (7) |
| TYRA Tyra Biosciences Inc | 08/13 | +24 % | 88 8/22 | Stage 1 | E 23 | 2 of 9 | 1.9 $ | Biotechnology | – | — | — | Healthcare | 31.90 $ | +14.3 % | +23.3 % | +191.7 % | −23.9 % | +62.9 % | 90 | 42 | 6.3 % | 6.2 % | 0.76 | — | 0.0 | — | 4.8 | — | — | -7.0 | — | — | 0.0 % | -36.9 % | -23.6 % | 0.02 | — | — | — | 0.0 % | 0.0 % | 20.5 | 111.6 % | 30.9 % | 4.8 (8) |
| CYTK Cytokinetics Inc | 08/06 | +8 % | 68 6/22 | Stage 2 | D 39 | 3 of 9 | 10.4 $ | Biotechnology | Neutral | — | Healthcare | 77.10 $ | +25.9 % | +36.0 % | +104.9 % | −2.6 % | +39.8 % | 88 | 42 | 4.6 % | 4.1 % | 0.42 | — | 117.6 | 97.8 | 57.5 | — | — | -15.8 | -948.7 % | -290.7 % | 0.0 % | -572.2 % | -31.5 % | -1.56 | -64.9 % | +376.6 % | — | 0.0 % | 0.0 % | -7.3 | 118.8 % | 19.4 % | 4.3 (21) | |
| CLSK CleanSpark Inc | 08/06 | +92 % | 54 5/22 | Stage 3 | D 42 | 2 of 9 | 3.6 $ | Capital Markets | – | — | — | Financial Services | 13.80 $ | +69.9 % | +34.8 % | +21.0 % | −32.8 % | +72.0 % | 88 | 95 | 9.5 % | 9.1 % | 3.84 | — | 36.1 | 4.9 | 3.6 | — | — | 29.8 | -246.3 % | 50.7 % | -67.7 % | -34.8 % | -18.2 % | 2.10 | 33.9 % | +102.2 % | — | 0.0 % | 0.0 % | 4.4 | 87.6 % | 42.5 % | 4.8 (12) |
| CGON CG Oncology, Inc. Common stock | 08/14 | — | 68 6/22 | Stage 2 | C 51 | 4 of 9 | 6.3 $ | Biotechnology | – | — | — | Healthcare | 71.20 $ | +58.3 % | +83.7 % | +166.7 % | −3.5 % | +27.4 % | 88 | 42 | 6.2 % | 5.5 % | 0.22 | — | 0.0 | 1,240.6 | 5.8 | — | — | 0.0 | -6,130.1 % | -2,670.9 % | 0.0 % | -20.8 % | -14.4 % | 0.01 | 96.2 % | +254.7 % | — | 0.0 % | 0.0 % | 33.4 | 109.9 % | 14.0 % | 4.4 (10) |
| KYMR Kymera Therapeutics Inc | 08/10 | +109 % | 54 5/22 | Stage 2 | D 36 | 4 of 9 | 8.6 $ | Biotechnology | – | — | — | Healthcare | 103.40 $ | +26.3 % | +31.5 % | +136.3 % | −10.5 % | +23.0 % | 87 | 42 | 8.9 % | 6.0 % | 1.96 | — | 0.0 | 166.8 | 4.7 | — | — | -9.5 | -244.9 % | -549.8 % | 0.0 % | -27.1 % | -17.2 % | 0.05 | 92.3 % | -16.7 % | — | 0.0 % | 0.0 % | 14.7 | 117.6 % | 15.5 % | 4.6 (20) |
| RHLD Resolute Holdings Management, Inc. | 08/06 | — | — | Stage 1 | D 43 | 3 of 9 | 0.0 $ | Specialty Business Services | – | — | — | Industrials | 123.80 $ | -40.0 % | -36.8 % | +205.4 % | −47.1 % | — | 87 | 50 | 6.6 % | 6.5 % | — | 17.4 | 0.0 | — | 32.8 | — | — | 43.2 | — | 47.2 % | 7.7 % | 1.2 % | 2.2 % | 72.19 | — | +9.9 % | — | 0.0 % | 0.0 % | 3.7 | 47.7 % | 12.2 % | — |
| MNPR Monopar Therapeutics Inc | 08/11 | -10 % | 89 8/22 | Stage 3 | D 32 | 4 of 9 | 0.6 $ | Biotechnology | Neutral | — | Healthcare | 108.40 $ | +25.2 % | +33.6 % | +163.1 % | −16.5 % | +7.8 % | 87 | 42 | 8.6 % | 7.6 % | 1.48 | — | 0.0 | — | 5.4 | — | — | -2.4 | — | — | 0.0 % | -15.9 % | -12.1 % | 0.00 | — | -100.0 % | — | 0.0 % | 0.0 % | 62.2 | 93.3 % | 29.7 % | 4.2 (5) | |
| CORT Corcept Therapeutics Incorporated | 07/30 | +25 % | 38 4/22 | Stage 3 | C 54 | 3 of 9 | 12.3 $ | Biotechnology | – | — | — | Healthcare | 114.50 $ | +129.5 % | +5.1 % | +70.5 % | −6.9 % | +18.1 % | 86 | 23 | 4.8 % | 4.7 % | 0.46 | 337.1 | 58.1 | 14.8 | 19.3 | 115.0 | 0.81 | 1,368.5 | -30.1 % | 98.3 % | 6.6 % | 7.2 % | 0.5 % | 0.02 | 78.3 % | +12.8 % | — | 0.0 % | 0.0 % | 11.8 | 75.7 % | 11.4 % | 4.5 (6) |
| MIRM Mirum Pharmaceuticals Inc | 08/05 | +102 % | 68 6/22 | Stage 2 | C 45 | 3 of 9 | 6.3 $ | Biotechnology | – | — | — | Healthcare | 106.00 $ | +40.6 % | +52.3 % | +105.0 % | −1.9 % | +38.2 % | 86 | 42 | 5.0 % | 5.0 % | 0.49 | — | 39.7 | 11.0 | 28.1 | — | — | 341.2 | -39.5 % | 81.4 % | -140.2 % | -335.8 % | -5.9 % | 1.34 | 27.2 % | +54.7 % | — | 0.0 % | 0.0 % | -5.4 | 114.4 % | 15.6 % | 4.6 (10) |
| ADV Advantage Solutions Inc | 08/06 | -10 % | 97 11/24 | Stage 2 | D 35 | 4 of 9 | 0.5 $ | Advertising Agencies | – | — | — | Communication Services | 39.20 $ | +81.0 % | +112.3 % | +14.6 % | −10.0 % | +8.4 % | 86 | 29 | 9.4 % | 8.9 % | 2.09 | — | 0.0 | 0.1 | 1.1 | 8.4 | — | 24.7 | — | 14.0 % | -6.8 % | -41.5 % | 2.3 % | 3.24 | — | -0.7 % | — | 0.0 % | 0.0 % | 0.4 | 30.8 % | 10.2 % | 3.7 (3) |
| DNLI Denali Therapeutics Inc | 08/10 | -5 % | 13 2/22 | Stage 2 | D 36 | 2 of 9 | 3.6 $ | Biotechnology | – | — | — | Healthcare | 23.00 $ | +50.0 % | +52.4 % | +66.5 % | −4.8 % | +49.2 % | 85 | 42 | 5.3 % | 5.3 % | 0.96 | — | 0.0 | — | 3.9 | — | — | 86.5 | 0.0 % | — | 0.0 % | -49.6 % | -27.0 % | 0.04 | 73.2 % | -100.0 % | — | 0.0 % | 0.0 % | 2.5 | 99.8 % | 10.7 % | 4.8 (19) |
| BRKR Bruker Corporation | 08/03 | -8 % | 25 3/22 | Stage 2 | C 46 | 4 of 9 | 9.8 $ | Medical Devices | – | — | — | Healthcare | 62.80 $ | +17.3 % | +24.4 % | +64.3 % | −5.7 % | -4.9 % | 84 | 6 | 4.4 % | 5.2 % | 1.29 | — | 15.2 | 2.8 | 3.9 | 191.3 | 1.52 | 36.2 | 6.2 % | 47.6 % | -0.3 % | -0.4 % | 2.7 % | 0.68 | 40.0 % | +2.1 % | — | 0.3 % | 14.8 % | 6.1 | 92.8 % | 18.5 % | 3.9 (14) |
| MSGS Madison Square Garden Sports Corp | 08/11 | +36 % | 75 7/24 | Stage 2 | D 32 | 4 of 9 | 9.5 $ | Entertainment | – | — | — | Communication Services | 393.70 $ | +43.3 % | +55.5 % | +94.8 % | −4.6 % | +12.1 % | 84 | 96 | 3.2 % | 2.9 % | 0.58 | — | 72.5 | 8.8 | 1.6 | 173.3 | — | 501.3 | 0.7 % | 29.4 % | -2.1 % | -12.3 % | -1.0 % | -3.95 | -19.6 % | +1.2 % | — | 0.0 % | 0.0 % | 1.2 | 93.7 % | 6.5 % | 4.1 (8) |
| VAC Marriot Vacations Worldwide | 08/03 | -3 % | 51 7/31 | Stage 2 | D 31 | 4 of 9 | 3.4 $ | Resorts & Casinos | – | — | — | Consumer Cyclical | 97.60 $ | +72.8 % | +80.7 % | +37.1 % | −3.2 % | -7.5 % | 84 | 13 | 4.3 % | 4.6 % | 1.23 | — | 7.0 | 0.7 | — | — | 1.48 | 407.6 | 14.3 % | 52.7 % | -10.3 % | -15.5 % | 2.7 % | — | 20.7 % | +1.3 % | — | 3.3 % | 76.3 % | 5.5 | 94.6 % | 11.3 % | 3.4 (11) |
| RAL Ralliant Corporation Common Stock | 08/10 | — | — | Stage 2 | D 38 | 4 of 9 | 0.0 $ | Electronic Components | – | — | — | Technology | 65.40 $ | +36.2 % | +40.5 % | +43.6 % | −2.5 % | -6.6 % | 83 | 50 | 3.8 % | 3.7 % | — | — | 37.9 | — | 4.9 | — | — | 20.1 | 12.7 % | 50.4 % | -58.6 % | -45.9 % | 3.7 % | 0.73 | 42.4 % | -4.0 % | — | 0.3 % | 8.5 % | 1.3 | 102.0 % | 8.6 % | — |
| BEAM Beam Therapeutics Inc | 08/04 | +2 % | 39 4/22 | Stage 2 | C 53 | 4 of 9 | 2.7 $ | Biotechnology | – | — | — | Healthcare | 25.50 $ | +19.8 % | +24.2 % | +29.5 % | −8.0 % | +105.1 % | 83 | 42 | 7.7 % | 7.2 % | 2.18 | — | 0.0 | 16.3 | 2.2 | — | — | -7.0 | -337.8 % | -146.9 % | -40.2 % | -5.8 % | -15.8 % | 0.22 | 78.6 % | +120.0 % | — | 0.0 % | 0.0 % | 8.3 | 107.0 % | 35.0 % | 4.4 (17) |
| IMNM Immunome Inc | 08/05 | +82 % | 56 5/22 | Stage 1 | C 45 | 3 of 9 | 2.6 $ | Biotechnology | – | — | — | Healthcare | 22.80 $ | -10.0 % | -5.8 % | +116.4 % | −29.8 % | +56.9 % | 81 | 42 | 5.0 % | 5.4 % | 2.07 | — | 0.0 | 639.8 | 4.5 | — | — | -0.7 | -5,698.8 % | -4,552.4 % | 0.0 % | -50.1 % | -29.7 % | 0.01 | 95.0 % | -23.2 % | — | 0.0 % | 0.0 % | 22.6 | 108.4 % | 17.8 % | 4.8 (9) |
| MPLT MapLight Therapeutics, Inc. Common Stock | 08/13 | — | — | Stage 2 | D 35 | 4 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 13.00 $ | +63.1 % | +89.3 % | — | −4.0 % | +23.7 % | 78 | 50 | 7.6 % | 8.1 % | — | — | 0.0 | — | — | — | — | 0.0 | — | — | 0.0 % | -81.0 % | -49.5 % | — | — | — | — | 0.0 % | 0.0 % | 23.8 | 56.0 % | 8.6 % | — |
| SRRK Scholar Rock Holding Corp | 08/05 | +8 % | 26 3/22 | Stage 2 | D 33 | 1 of 9 | 5.7 $ | Biotechnology | – | — | — | Healthcare | 47.30 $ | +16.4 % | +19.8 % | +27.7 % | −0.1 % | +25.4 % | 77 | 42 | 4.7 % | 4.7 % | 0.68 | — | 0.0 | — | 20.9 | — | — | -2.1 | 0.0 % | — | 0.0 % | -138.9 % | -54.3 % | 0.75 | 51.6 % | -100.0 % | — | 0.0 % | 0.0 % | -3.7 | 116.6 % | 18.4 % | 4.6 (10) |
| PTCT PTC Therapeutics Inc | 08/06 | +33 % | 68 6/22 | Stage 2 | C 53 | 2 of 9 | 5.6 $ | Biotechnology | – | — | — | Healthcare | 68.00 $ | +8.1 % | +4.1 % | +30.5 % | −3.4 % | +42.5 % | 75 | 42 | 4.7 % | 4.0 % | 0.53 | — | 35.6 | 5.6 | 1,402.7 | — | 0.81 | 23.9 | 16.5 % | 50.0 % | -3.8 % | -7,740.1 % | 2.5 % | -2.19 | -6.3 % | +114.5 % | — | 0.0 % | 0.0 % | 2.5 | 117.7 % | 16.1 % | 3.9 (14) |
| PII Polaris Industries Inc | 08/04 | -11 % | 21 4/31 | Stage 2 | D 41 | 4 of 9 | 3.8 $ | Recreational Vehicles | – | — | — | Consumer Cyclical | 67.10 $ | +10.9 % | +9.5 % | +32.4 % | −4.1 % | +7.3 % | 75 | 4 | 4.1 % | 4.2 % | 1.26 | — | 45.2 | 0.5 | 5.1 | 23.8 | 3.34 | 53.8 | -0.4 % | 22.0 % | -3.5 % | -44.9 % | 2.6 % | 2.94 | 14.3 % | -0.3 % | — | 4.1 % | 104.6 % | 3.2 | 98.5 % | 10.8 % | 3.2 (18) |
| XENE Xenon Pharmaceuticals Inc | 08/10 | +12 % | 39 4/22 | Stage 2 | D 39 | 4 of 9 | 6.1 $ | Biotechnology | – | — | — | Healthcare | 62.70 $ | +21.8 % | +33.6 % | +105.2 % | −11.2 % | +29.1 % | 73 | 42 | 3.6 % | 3.2 % | 0.61 | — | 0.0 | — | 4.5 | — | — | 34.2 | 0.0 % | — | 0.0 % | -37.5 % | -24.2 % | 0.01 | 96.5 % | -100.0 % | — | 0.0 % | 0.0 % | 31.9 | 107.4 % | 6.6 % | 4.7 (19) |
| LGIH LGI Homes | 08/04 | -19 % | 8 2/31 | Stage 2 | D 36 | 4 of 9 | 1.2 $ | Residential Construction | – | — | — | Consumer Cyclical | 54.60 $ | +30.5 % | +47.6 % | +2.4 % | −9.9 % | +70.3 % | 73 | 16 | 6.5 % | 6.0 % | 1.82 | — | 18.8 | 0.7 | — | — | 0.69 | 35.0 | -0.1 % | 20.5 % | 4.2 % | 3.4 % | 1.3 % | — | 52.4 % | -22.6 % | — | 0.0 % | 0.0 % | 12.1 | 91.2 % | 20.4 % | 3.0 (6) |
| SN SharkNinja, Inc. | 08/06 | — | 42 6/31 | Stage 2 | C 54 | 3 of 9 | 22.9 $ | Furnishings, Fixtures & Appliances | – | — | — | Consumer Cyclical | 161.80 $ | +20.6 % | +29.7 % | +39.3 % | −2.1 % | +5.4 % | 72 | 53 | 4.2 % | 4.5 % | 1.18 | 33.1 | 25.9 | 3.5 | 8.4 | 60.5 | 2.59 | 21.3 | 11.7 % | 49.0 % | 10.7 % | 29.4 % | 12.9 % | 0.31 | 55.1 % | +15.8 % | — | 0.0 % | 0.0 % | 9.4 | 61.7 % | 13.3 % | 4.7 (12) |
| ADM Archer-Daniels-Midland Company | 08/04 | +5 % | 77 5/16 | Stage 2 | C 50 | 4 of 9 | 38.4 $ | Farm Products | – | — | — | Consumer Defensive | 79.30 $ | +33.8 % | +34.9 % | +50.9 % | −10.3 % | -4.8 % | 70 | 52 | 2.8 % | 2.8 % | 0.61 | 35.5 | 16.5 | 0.5 | 1.7 | 8.0 | 2.40 | 15.7 | 1.3 % | 6.3 % | 1.3 % | 4.8 % | 1.7 % | 0.59 | 41.0 % | -6.2 % | — | 2.6 % | 82.4 % | 6.3 | 87.1 % | 4.6 % | 3.0 (12) |
| NWL Newell Brands Inc | 08/07 | -8 % | 46 3/16 | Stage 3 | C 49 | 3 of 9 | 2.4 $ | Household & Personal Products | Uses AI | — | Consumer Defensive | 5.60 $ | +42.5 % | +70.6 % | +6.7 % | −11.3 % | +4.4 % | 70 | 52 | 7.2 % | 6.8 % | 0.86 | — | 9.5 | 0.3 | — | 14.4 | 0.97 | 22.6 | 2.7 % | 35.3 % | -3.1 % | -11.2 % | 3.2 % | — | 21.6 % | -5.0 % | — | 5.0 % | 38.9 % | 2.7 | 99.2 % | 22.7 % | 3.2 (9) | |
| BIIB Biogen Inc. | 07/30 | -10 % | 96 10/22 | Stage 2 | C 49 | 4 of 9 | 30.0 $ | Drug Manufacturers - General | Uses AI | — | Healthcare | 203.00 $ | +14.9 % | +16.3 % | +58.6 % | −6.7 % | +15.4 % | 69 | 71 | 3.5 % | 3.0 % | 0.16 | 21.6 | 17.3 | 3.0 | 1.6 | 12.3 | 5.09 | 17.3 | 22.9 % | 78.3 % | 8.3 % | 7.7 % | 5.2 % | 0.35 | 62.0 % | +1.4 % | — | 0.0 % | 0.0 % | 3.4 | 96.4 % | 4.5 % | 3.8 (37) | |
| PCVX Vaxcyte Inc | 08/05 | -1 % | 68 6/22 | Stage 1 | D 28 | 1 of 9 | 7.8 $ | Biotechnology | – | — | — | Healthcare | 54.10 $ | +12.6 % | +21.1 % | +59.3 % | −17.4 % | +101.5 % | 69 | 42 | 4.8 % | 4.5 % | 1.22 | — | 0.0 | — | 2.7 | — | — | -14.4 | 0.0 % | — | 0.0 % | -30.6 % | -20.2 % | 0.04 | 89.5 % | — | — | 0.0 % | 0.0 % | 11.0 | 114.6 % | 9.9 % | 4.9 (10) |
| XNCR Xencor Inc | 08/05 | -15 % | 14 2/22 | Stage 3 | D 32 | 2 of 9 | 1.5 $ | Biotechnology | – | — | — | Healthcare | 20.20 $ | -8.0 % | +1.0 % | +142.9 % | −21.1 % | +40.3 % | 69 | 42 | 6.5 % | 5.7 % | 0.86 | — | 68.0 | 15.3 | 3.0 | — | — | -17.3 | — | -152.2 % | -177.1 % | -29.8 % | -16.2 % | 0.34 | — | +13.7 % | — | 0.0 % | 0.0 % | 4.0 | 115.5 % | 20.8 % | 4.5 (12) |
| IPGP IPG Photonics Corporation | 08/04 | -6 % | 80 8/25 | Stage 2 | C 53 | 3 of 9 | 4.0 $ | Semiconductor Equipment & Materials | – | — | — | Technology | 85.10 $ | +50.3 % | +48.5 % | +13.6 % | −29.3 % | +55.0 % | 68 | 13 | 5.8 % | 6.6 % | 0.94 | 121.7 | 56.5 | 3.8 | 1.7 | — | 1.83 | 30.6 | 2.1 % | 37.6 % | 2.8 % | 1.4 % | 0.6 % | 0.01 | 87.4 % | +2.7 % | — | 0.0 % | 0.0 % | 17.4 | 71.8 % | 20.2 % | 3.1 (9) |
| DKS Dick’s Sporting Goods Inc | — | +30 % | 42 6/31 | Stage 3 | C 54 | 4 of 9 | 17.5 $ | Specialty Retail | – | — | — | Consumer Cyclical | 195.90 $ | +21.0 % | +11.9 % | -5.2 % | −2.9 % | +27.7 % | 66 | 58 | 4.1 % | 4.3 % | 1.22 | 19.2 | 13.7 | 0.9 | 3.1 | 28.9 | 1.35 | 13.1 | 10.6 % | 33.6 % | 4.7 % | 20.9 % | 7.4 % | 1.63 | 31.4 % | +28.1 % | — | 2.6 % | 36.5 % | 6.4 | 102.9 % | 14.6 % | 4.0 (26) |
| SWK Stanley Black & Decker Inc | 07/29 | +3 % | 9 2/29 | Stage 2 | C 51 | 3 of 9 | 15.1 $ | Tools & Accessories | – | — | — | Industrials | 94.60 $ | +15.3 % | +27.8 % | +46.2 % | −1.3 % | +2.4 % | 65 | 19 | 4.3 % | 3.7 % | 1.16 | 38.6 | 17.5 | 1.0 | 1.6 | 11.8 | 1.39 | 10.2 | 6.4 % | 32.2 % | 4.1 % | 4.2 % | 3.8 % | 3.81 | 41.6 % | -1.5 % | — | 3.6 % | 63.7 % | 5.7 | 95.7 % | 4.6 % | 3.4 (20) |
| ASTE Astec Industries Inc | 08/05 | +12 % | 18 3/29 | Stage 2 | C 48 | 3 of 9 | 1.2 $ | Farm & Heavy Construction Machinery | – | — | — | Industrials | 50.70 $ | +31.5 % | +33.9 % | +29.1 % | −6.0 % | +43.0 % | 65 | 4 | 4.2 % | 4.1 % | 1.34 | — | 12.6 | 0.8 | — | 32.0 | 1.15 | 14.2 | 3.7 % | 26.4 % | 1.8 % | 3.9 % | 4.3 % | — | 47.5 % | +8.1 % | — | 1.0 % | 25.1 % | 7.9 | 98.1 % | 3.0 % | 4.0 (2) |
| SAH Sonic Automotive Inc | 07/23 | +28 % | 51 7/31 | Stage 2 | D 41 | 3 of 9 | 2.9 $ | Auto & Truck Dealerships | – | — | — | Consumer Cyclical | 91.60 $ | +33.1 % | +33.1 % | +29.4 % | −7.7 % | +7.2 % | 63 | 26 | 3.3 % | 3.6 % | 0.90 | 29.5 | 13.4 | 0.2 | 2.9 | — | 0.44 | 11.3 | — | 15.7 % | 1.4 % | 10.5 % | 5.3 % | 4.51 | — | +6.5 % | — | 1.8 % | 24.3 % | 4.8 | 74.4 % | 22.5 % | 3.9 (9) |
| TRAX First Tracks Biotherapeutics, Inc. | — | — | — | Stage 2 | D 28 | — | 0.0 $ | Biotechnology | – | — | — | Healthcare | 44.00 $ | — | — | — | −38.9 % | +132.9 % | 63 | 50 | 9.2 % | 10.1 % | — | — | 0.0 | — | 2.3 | — | — | 0.0 | — | — | 0.0 % | -48.9 % | -29.0 % | — | — | — | — | 0.0 % | 0.0 % | — | 46.0 % | — | — |
| BBIO BridgeBio Pharma Inc | 08/04 | +113 % | 68 6/22 | Stage 1 | C 54 | 3 of 9 | 15.7 $ | Biotechnology | – | — | — | Healthcare | 80.10 $ | -10.3 % | -5.9 % | +69.4 % | −18.0 % | +31.4 % | 59 | 42 | 3.7 % | 4.0 % | 0.95 | — | 0.0 | 27.0 | 142.2 | — | — | -9.4 | -54.5 % | 95.1 % | -124.4 % | -1,789.7 % | -28.0 % | -1.49 | -165.5 % | +126.3 % | — | 0.0 % | 0.0 % | -7.9 | 103.2 % | 14.7 % | 4.4 (19) |
| VKTX Viking Therapeutics Inc | 07/22 | -8 % | 54 5/22 | Stage 3 | E 19 | 1 of 9 | 3.7 $ | Biotechnology | – | — | — | Healthcare | 31.70 $ | -1.1 % | +5.9 % | -2.6 % | −14.3 % | +193.4 % | 59 | 42 | 6.8 % | 5.3 % | 0.66 | — | 0.0 | — | — | — | — | -71.6 | 0.0 % | — | 0.0 % | -70.0 % | -42.5 % | — | 82.5 % | -100.0 % | — | 0.0 % | 0.0 % | 3.0 | 64.5 % | 21.1 % | 4.4 (19) |
| CLFD Clearfield Inc | 08/05 | -6 % | 35 4/25 | Stage 2 | D 42 | 3 of 9 | 0.4 $ | Communication Equipment | Neutral | — | Technology | 30.30 $ | +27.5 % | +31.7 % | -30.9 % | −28.6 % | +44.4 % | 59 | 5 | 5.9 % | 7.3 % | 2.11 | 135.2 | 18.3 | 3.2 | 1.7 | 27.3 | — | 29.1 | — | 34.0 % | -5.8 % | 1.3 % | -0.3 % | 0.05 | — | -9.9 % | — | 0.0 % | 0.0 % | 20.8 | 61.2 % | 13.3 % | 4.5 (4) | |
| EPR EPR Properties | 07/29 | +23 % | 30 3/21 | Stage 2 | C 49 | 4 of 9 | 4.8 $ | REIT - Specialty | – | — | — | Real Estate | 62.10 $ | +21.9 % | +22.1 % | +20.4 % | −4.9 % | -0.2 % | 58 | 29 | 2.2 % | 2.0 % | 1.02 | 19.5 | 18.5 | 6.5 | 2.1 | 10.8 | 2.93 | 14.3 | 51.3 % | 91.9 % | 35.6 % | 11.7 % | 4.3 % | 1.35 | 40.8 % | +12.1 % | — | 6.0 % | 32.2 % | 4.4 | 84.4 % | 14.1 % | 3.3 (12) |
| HTFL Heartflow, Inc. | — | — | — | Stage 3 | C 51 | 4 of 9 | 0.0 $ | Health Information Services | – | — | — | Healthcare | 25.20 $ | +18.3 % | +14.5 % | — | −15.1 % | +5.8 % | 58 | 50 | 5.4 % | 7.0 % | — | — | 0.0 | — | — | — | — | 0.0 | — | 78.1 % | -58.4 % | -135.3 % | -16.2 % | — | — | +39.9 % | — | 0.0 % | 0.0 % | -0.9 | 78.8 % | 7.1 % | — |
| PKG Packaging Corp of America | 07/22 | +32 % | 32 5/31 | Stage 2 | C 53 | 4 of 9 | 21.9 $ | Packaging & Containers | – | — | — | Consumer Cyclical | 245.80 $ | +14.3 % | +16.1 % | +30.0 % | −3.4 % | +4.4 % | 57 | 25 | 2.6 % | 2.8 % | 0.82 | 30.0 | 23.5 | 2.4 | 4.8 | 31.2 | 1.93 | 24.8 | 13.5 % | 20.8 % | 7.3 % | 16.3 % | 8.4 % | 1.36 | 42.6 % | +7.2 % | — | 2.4 % | 53.6 % | 7.2 | 100.0 % | 4.7 % | 4.1 (11) |
| CRL Charles River Laboratories | 08/05 | -3 % | 53 5/22 | Stage 3 | D 35 | 3 of 9 | 10.9 $ | Diagnostics & Research | – | — | — | Healthcare | 232.50 $ | -6.5 % | +11.0 % | +37.1 % | −7.1 % | -1.7 % | 57 | 24 | 4.3 % | 4.8 % | 1.40 | — | 20.9 | 2.7 | 3.9 | 27.9 | 0.12 | 48.4 | 15.9 % | 34.5 % | -4.6 % | -5.9 % | 4.3 % | 1.04 | 38.0 % | -0.9 % | — | 0.0 % | 0.0 % | 4.8 | 123.4 % | 8.0 % | 3.3 (19) |
| COLM Columbia Sportswear Company | 07/30 | -3 % | 8 2/31 | Stage 2 | D 42 | 3 of 9 | 3.0 $ | Apparel Manufacturing | – | — | — | Consumer Cyclical | 59.40 $ | +17.3 % | +11.9 % | +7.3 % | −7.5 % | +17.6 % | 57 | 25 | 3.6 % | 3.5 % | 0.94 | — | 14.8 | 0.9 | — | 17.4 | 2.19 | 8.4 | 5.4 % | 52.2 % | 6.1 % | 10.3 % | 6.3 % | — | 61.7 % | +0.8 % | — | 2.0 % | 41.1 % | 10.4 | 52.9 % | 14.6 % | 3.4 (8) |
| ZBIO Zenas BioPharma, Inc. | 08/11 | — | 81 7/22 | Stage 4 | D 41 | 2 of 9 | 2.0 $ | Biotechnology | – | — | — | Healthcare | 31.40 $ | -44.4 % | -40.8 % | +100.1 % | −44.7 % | +38.5 % | 57 | 42 | 8.2 % | 7.6 % | — | — | 0.0 | 203.7 | — | — | — | 0.0 | — | — | 0.0 % | -137.1 % | -29.1 % | — | — | +100.0 % | — | 0.0 % | 0.0 % | 2.6 | 90.5 % | 28.7 % | 4.7 (7) |
| W Wayfair Inc | 08/03 | +16 % | 8 2/31 | Stage 4 | D 42 | 3 of 9 | 11.2 $ | Internet Retail | – | — | — | Consumer Cyclical | 84.90 $ | -15.5 % | -5.0 % | +29.3 % | −22.1 % | +12.7 % | 56 | 13 | 6.5 % | 6.8 % | 2.96 | — | 30.7 | 0.9 | 2,432.5 | 24.6 | 23.50 | 107.7 | 0.4 % | 30.4 % | -2.4 % | 0.0 % | 3.7 % | -1.28 | -99.0 % | +5.1 % | — | 0.0 % | 0.0 % | -4.4 | 113.3 % | 18.1 % | 3.8 (35) |
| HOV Hovnanian Enterprises Inc | 08/20 | +13 % | 8 2/31 | Stage 3 | D 37 | 2 of 9 | 0.7 $ | Residential Construction | – | — | — | Consumer Cyclical | 123.90 $ | +30.7 % | +43.6 % | +3.7 % | −12.5 % | -40.3 % | 56 | 21 | 6.9 % | 6.5 % | 1.81 | 35.7 | 13.5 | 0.2 | 1.1 | 2.6 | 2.00 | 14.0 | — | 15.2 % | 1.3 % | 4.4 % | 2.0 % | 1.13 | — | -0.9 % | — | 0.0 % | 0.0 % | 7.4 | 65.0 % | 7.3 % | 3.0 (1) |
| IRON Disc Medicine Inc. | 08/06 | +11 % | 28 3/22 | Stage 4 | D 36 | 2 of 9 | 3.0 $ | Biotechnology | – | — | — | Healthcare | 77.00 $ | -11.3 % | -7.4 % | +28.9 % | −29.5 % | +31.2 % | 54 | 42 | 4.3 % | 4.6 % | 2.07 | — | 0.0 | — | 4.6 | — | — | -7.6 | 0.0 % | — | 0.0 % | -35.8 % | -24.0 % | 0.05 | 91.8 % | — | — | 0.0 % | 0.0 % | 16.6 | 113.7 % | 22.3 % | 4.7 (11) |
| LYV Live Nation Entertainment Inc | 08/06 | +31 % | 63 6/24 | Stage 2 | C 53 | 2 of 9 | 41.0 $ | Entertainment | – | — | — | Communication Services | 174.10 $ | +18.3 % | +25.6 % | +17.9 % | −0.7 % | +16.0 % | 51 | 13 | 2.8 % | 2.8 % | 1.11 | — | 500.0 | 1.6 | 135.9 | 29.2 | 17.90 | 25.3 | -9.9 % | 25.8 % | 0.5 % | 14.9 % | 2.1 % | -3.44 | -0.5 % | +8.8 % | — | 0.0 % | 0.0 % | 2.8 | 85.6 % | 16.1 % | 4.4 (23) |
| PAG Penske Automotive Group Inc | 07/29 | +7 % | 43 6/31 | Stage 2 | D 42 | 4 of 9 | 14.3 $ | Auto & Truck Dealerships | – | — | — | Consumer Cyclical | 217.30 $ | +13.6 % | +10.2 % | +34.2 % | −3.0 % | -5.4 % | 51 | 28 | 2.8 % | 2.8 % | 0.87 | — | 16.2 | 0.4 | — | 26.0 | 2.75 | 13.9 | 3.7 % | 16.2 % | 2.8 % | 16.5 % | 4.2 % | — | 31.0 % | -0.2 % | — | 2.7 % | 44.2 % | 5.2 | 80.0 % | 14.6 % | 3.7 (11) |
| HUN Huntsman Corporation | 07/30 | -16 % | 37 4/23 | Stage 1 | D 39 | 1 of 9 | 1.7 $ | Chemicals | – | — | — | Basic Materials | 9.80 $ | +15.2 % | +12.0 % | +5.1 % | −29.6 % | +36.1 % | 50 | 66 | 6.9 % | 5.2 % | 0.71 | — | 153.8 | 0.3 | 0.6 | 12.9 | 2.22 | 11.7 | -0.4 % | 13.5 % | -3.1 % | -8.9 % | 0.0 % | 0.93 | 37.6 % | -5.9 % | — | 3.6 % | 180.0 % | 5.0 | 101.5 % | 10.9 % | 3.1 (15) |
| IBTA Ibotta, Inc. | 08/12 | — | 92 10/25 | Stage 2 | D 32 | 4 of 9 | 0.6 $ | Software - Application | – | — | — | Technology | 24.00 $ | +35.6 % | +53.5 % | -34.0 % | −22.5 % | +39.3 % | 50 | 4 | 6.1 % | 5.8 % | -0.58 | — | 24.7 | 1.6 | 2.2 | 7.2 | — | 2,688.0 | — | 78.4 % | -2.2 % | -2.3 % | -0.9 % | 0.10 | — | -6.8 % | — | 0.0 % | 0.0 % | 5.6 | 50.9 % | 28.9 % | 3.8 (9) |
| WAT Waters Corporation | 08/03 | +13 % | 24 3/22 | Stage 3 | C 50 | 2 of 9 | 37.0 $ | Diagnostics & Research | – | — | — | Healthcare | 377.20 $ | -6.0 % | -4.1 % | +30.7 % | −9.0 % | +9.6 % | 49 | 30 | 3.1 % | 3.3 % | 1.20 | 47.7 | 26.4 | 9.8 | 2.4 | 140.3 | 1.69 | 42.6 | 2.8 % | 55.2 % | 11.9 % | 5.2 % | 3.3 % | 0.93 | 62.3 % | +7.0 % | — | 0.0 % | 0.0 % | 7.0 | 99.7 % | 3.7 % | 3.6 (22) |
| DHI DR Horton Inc | 07/21 | +11 % | 51 7/31 | Stage 3 | D 43 | 2 of 9 | 40.5 $ | Residential Construction | – | — | — | Consumer Cyclical | 143.10 $ | +9.0 % | +12.7 % | +1.3 % | −9.5 % | +14.7 % | 48 | 25 | 3.7 % | 3.3 % | 1.36 | 13.4 | 12.2 | 1.2 | 1.7 | 12.7 | 1.20 | 11.5 | 11.3 % | 21.3 % | 9.2 % | 13.1 % | 6.9 % | 0.28 | 66.4 % | -6.9 % | — | 1.3 % | 17.1 % | 14.9 | 88.9 % | 5.7 % | 3.6 (21) |
| LLYVK Liberty Live Holdings, Inc. Series C Liberty Live Group Common Stock | 08/06 | — | — | Stage 2 | D 32 | 4 of 9 | 0.0 $ | Entertainment | – | — | — | Communication Services | 98.60 $ | +17.5 % | +25.3 % | +17.1 % | −2.0 % | +12.7 % | 48 | 50 | 3.2 % | 3.3 % | 0.94 | — | 129.9 | — | 0.3 | — | — | 62.0 | -26.2 % | 20.1 % | -88.2 % | 0.0 % | -2.1 % | 0.07 | 48.7 % | -98.4 % | — | 0.0 % | 0.0 % | 5.2 | 80.4 % | 4.2 % | 1.0 (1) |
| RARE Ultragenyx | 08/04 | -14 % | 69 6/22 | Stage 3 | D 37 | 0 of 9 | 2.5 $ | Biotechnology | – | — | — | Healthcare | 24.90 $ | +25.0 % | -11.3 % | -8.8 % | −31.0 % | +114.3 % | 48 | 42 | 5.5 % | 5.2 % | 0.31 | — | 0.0 | 3.7 | — | — | — | -6.5 | -102.2 % | -28.1 % | -90.9 % | -608.5 % | -25.5 % | — | -18.2 % | +20.1 % | — | 0.0 % | 0.0 % | -9.9 | 104.2 % | 14.1 % | 4.6 (20) |
| LLYVA Liberty Live Holdings, Inc. Series A Liberty Live Group Common Stock | 08/06 | — | — | Stage 2 | D 31 | 4 of 9 | 0.0 $ | Entertainment | – | — | — | Communication Services | 94.70 $ | +16.2 % | +24.0 % | +15.8 % | −1.5 % | +7.9 % | 47 | 50 | 3.3 % | 3.3 % | 0.94 | — | 126.6 | — | 0.3 | — | — | 62.0 | -26.2 % | 20.1 % | -88.2 % | 0.0 % | -2.1 % | 0.01 | 48.7 % | -98.4 % | — | 0.0 % | 0.0 % | 5.2 | 80.4 % | 5.5 % | 1.0 (1) |
| PHM PulteGroup Inc | 07/22 | +23 % | 32 5/31 | Stage 3 | D 41 | 4 of 9 | 24.1 $ | Residential Construction | – | — | — | Consumer Cyclical | 126.50 $ | +8.4 % | +16.1 % | +12.9 % | −6.0 % | +11.2 % | 45 | 20 | 3.9 % | 3.3 % | 1.19 | 12.2 | 12.2 | 1.5 | 1.9 | 17.5 | 1.11 | 9.4 | 13.1 % | 25.6 % | 11.6 % | 16.2 % | 9.2 % | 0.19 | 71.2 % | -3.5 % | — | 0.8 % | 9.9 % | 13.3 | 96.9 % | 6.4 % | 4.0 (17) |
| CCS Century Communities Inc | 07/22 | -3 % | 63 5/21 | Stage 3 | D 37 | 3 of 9 | 1.9 $ | Real Estate - Development | – | — | — | Real Estate | 67.20 $ | +6.9 % | +24.0 % | +21.7 % | −8.5 % | +16.1 % | 45 | 19 | 5.2 % | 4.4 % | 1.29 | — | 18.7 | 0.5 | — | 154.1 | 0.45 | 17.0 | 4.3 % | 17.9 % | 3.4 % | 5.2 % | 2.7 % | — | 56.6 % | -6.4 % | — | 1.8 % | 23.1 % | 11.8 | 93.1 % | 9.4 % | 3.5 (4) |
| U Unity Software Inc | 08/05 | -9 % | 60 6/25 | Stage 4 | C 46 | 3 of 9 | 13.6 $ | Software - Application | – | — | — | Technology | 31.70 $ | -37.5 % | -37.7 % | -5.0 % | −48.8 % | +12.7 % | 44 | 42 | 5.1 % | 5.9 % | 2.05 | — | 33.8 | 7.1 | 4.7 | 29.4 | — | 134.6 | -15.2 % | 74.7 % | -35.0 % | -20.1 % | -4.0 % | 0.75 | 45.6 % | +2.0 % | — | 0.0 % | 0.0 % | 2.7 | 81.9 % | 7.8 % | 4.0 (29) |
| WAL Western Alliance Bancorporation | 07/16 | +49 % | 1 0/22 | Stage 1 | C 50 | 4 of 9 | 8.6 $ | Banks - Regional | – | — | — | Financial Services | 80.50 $ | -3.0 % | -3.4 % | +5.9 % | −16.2 % | +14.7 % | 42 | 28 | 2.9 % | 2.9 % | 1.33 | 9.4 | 8.0 | 2.0 | 1.2 | — | 1.47 | 0.0 | 31.8 % | 100.0 % | 28.2 % | 13.0 % | 1.1 % | 0.90 | 7.7 % | +5.2 % | — | 2.1 % | 20.5 % | -1.0 | 87.1 % | 0.0 % | 4.2 (15) |
| NSP Insperity Inc | 08/07 | -21 % | 96 13/29 | Stage 3 | D 43 | 3 of 9 | 1.8 $ | Staffing & Employment Services | Uses AI | — | Industrials | 50.60 $ | +0.1 % | +16.0 % | -8.6 % | −39.3 % | +2.3 % | 42 | 19 | 7.8 % | 6.7 % | 0.57 | — | 27.2 | 0.3 | 31.1 | 9.2 | 1.42 | 27.1 | 3.3 % | 12.9 % | -0.2 % | -26.9 % | -0.1 % | 6.42 | 3.1 % | +3.5 % | — | 4.7 % | 3.9 % | 4.7 | 111.8 % | 12.4 % | 3.0 (5) | |
| BHF Brighthouse Financial, Inc. | 08/06 | +15 % | 96 10/22 | Stage 2 | D 33 | 3 of 9 | 3.6 $ | Insurance - Life | – | — | — | Financial Services | 61.90 $ | -2.0 % | -1.8 % | +29.4 % | −5.4 % | +5.0 % | 41 | 5 | 1.0 % | 1.0 % | 0.87 | — | 3.3 | 0.7 | 0.6 | — | — | 0.0 | -63.4 % | 25.6 % | -1.1 % | -1.1 % | 0.1 % | 0.57 | 2.4 % | +42.2 % | — | 0.0 % | 0.0 % | 3.7 | 95.1 % | 10.6 % | 3.0 (9) |
| CSL Carlisle Companies Incorporated | 07/29 | +17 % | 9 2/29 | Stage 2 | D 44 | 4 of 9 | 14.6 $ | Building Products & Equipment | – | — | — | Industrials | 359.90 $ | +11.0 % | +14.5 % | +2.7 % | −10.9 % | +14.5 % | 40 | 30 | 5.2 % | 3.9 % | 0.85 | 21.0 | 18.0 | 2.9 | 8.8 | 16.8 | 1.20 | 13.2 | 17.4 % | 35.3 % | 14.2 % | 38.2 % | 10.8 % | 24.86 | 27.6 % | +0.3 % | — | 1.2 % | 21.8 % | 10.4 | 103.8 % | 7.9 % | 4.0 (7) |
| LII Lennox International Inc | 07/22 | +24 % | 36 5/29 | Stage 3 | C 50 | 4 of 9 | 14.9 $ | Building Products & Equipment | – | — | — | Industrials | 415.90 $ | +8.1 % | +15.0 % | -31.0 % | −17.2 % | +22.9 % | 39 | 28 | 3.7 % | 3.9 % | 1.16 | 18.3 | 18.0 | 2.8 | 11.8 | 22.5 | 1.25 | 14.0 | 14.3 % | 33.3 % | 14.9 % | 76.8 % | 16.0 % | 2.75 | 28.3 % | -2.7 % | — | 1.3 % | 23.4 % | 10.2 | 87.4 % | 8.9 % | 3.0 (21) |
| TXT Textron Inc | 07/23 | +11 % | 66 8/29 | Stage 1 | C 52 | 4 of 9 | 14.9 $ | Aerospace & Defense | – | — | — | Industrials | 85.30 $ | -0.8 % | -0.7 % | +9.7 % | −12.3 % | +19.4 % | 36 | 59 | 3.2 % | 2.7 % | 0.91 | 16.7 | 13.2 | 1.0 | 1.9 | 20.8 | 1.14 | 9.9 | 8.0 % | 17.6 % | 6.1 % | 12.3 % | 4.6 % | 0.68 | 44.1 % | +8.0 % | — | 0.1 % | 1.3 % | 7.1 | 91.6 % | 4.3 % | 3.8 (18) |
| LAD Lithia Motors Inc | 08/04 | +2 % | 42 6/31 | Stage 4 | D 41 | 2 of 9 | 8.7 $ | Auto & Truck Dealerships | – | — | — | Consumer Cyclical | 385.40 $ | -10.2 % | -15.3 % | +34.9 % | −17.7 % | +11.4 % | 35 | 16 | 3.3 % | 3.5 % | 1.26 | 13.2 | 10.7 | 0.2 | 1.4 | — | 0.80 | 11.2 | 3.6 % | 15.4 % | 1.9 % | 10.9 % | 3.9 % | 4.12 | 24.8 % | +4.0 % | — | 0.7 % | 7.0 % | 4.8 | 113.7 % | 17.4 % | 4.4 (16) |
| BIO Bio-Rad Laboratories Inc | 07/30 | -9 % | 79 7/22 | Stage 4 | D 43 | 4 of 9 | 8.7 $ | Medical Devices | – | — | — | Healthcare | 325.50 $ | -10.8 % | -2.1 % | +34.5 % | −13.1 % | -8.8 % | 35 | 5 | 3.6 % | 3.7 % | 1.09 | 54.5 | 36.8 | 3.4 | 1.3 | 24.4 | 1.19 | 19.2 | 5.8 % | 52.0 % | 6.5 % | 2.5 % | 1.8 % | 0.20 | 70.0 % | +0.7 % | — | 0.0 % | 0.0 % | 9.8 | 94.4 % | 0.0 % | 4.0 (6) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Bonde's dollar breakdown (original Stockbee formula 'o−c ≥ 0.90'): the stock closes at least $0.90 below its opening price — sustained selling pressure across the whole trading day, measured in dollars. Minimum daily volume 100,000 shares, average volume (50 days) ≥ 100,000 as a liquidity filter. Opening price calculated from the prior close and the gap.
All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 134 stocks pass this scanner's criteria (as of 3. August 2026). The 100 strongest hits are shown.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Fundamental Rating ≥ 55 out of 100) are excluded.
This scanner deliberately hunts for red flags — a hit is a finding, not a recommendation: like a smoke detector that beeps so you look in time. A hit is also not a bankruptcy verdict; most companies save themselves (say, through a capital raise, which dilutes existing shareholders). Portfolio owners use the list as an early-warning system, bargain hunters as an anti-shopping list, experienced traders as a watch list — it is never a buy or short recommendation.
Related scanners
- Altman Z: Distress Zone
- Bankruptcy Study: Stacked Warning Signals
- Below the 50- & 200-SMA
- Beneish M-Score
- Downward Momentum
- Going Concern (Distress Proxy)
- Insolvency Radar: Cash Running Low
- Kathy Donnelly: Liquid Movers Down
- Mike Webster: Overextended (Webby RSI)
- Near 52-Week Low
- Pradeep Bonde: 4% Breakout Bearish
- Qullamaggie: Parabolic (Short-Watch)
- RS Weakness (≤10)
- Stage 4 (Downtrend)
- Stan Weinstein: Stage 4
- Stan Weinstein: Stage 4B-
- Thomas Insolvency Candidate
- Weakness Cluster
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.